-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HztY846okua+HeJT74bLKWQ7P9Bjgu2wCihbiVQNeixExzvTadJeAUm5DAZsRWHZ pjGFNkyziGksRP7h8W4GKA== 0001047469-08-013308.txt : 20081219 0001047469-08-013308.hdr.sgml : 20081219 20081219170340 ACCESSION NUMBER: 0001047469-08-013308 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20081219 DATE AS OF CHANGE: 20081219 EFFECTIVENESS DATE: 20081219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23731 FILM NUMBER: 081261816 BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 DEFA14A 1 a2189791zdefa14a.htm DEFA14A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934

  Filed by the Registrant ý

 

Filed by a Party other than the Registrant o

 

Check the appropriate box:

 

o

 

Preliminary Proxy Statement

 

o

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

o

 

Definitive Proxy Statement

 

ý

 

Definitive Additional Materials

 

o

 

Soliciting Material Pursuant to §240.14a-12

Nutraceutical International Corporation

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
         
Payment of Filing Fee (Check the appropriate box):

ý

 

No fee required.

o

 

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
    (1)   Title of each class of securities to which transaction applies:
        
 
    (2)   Aggregate number of securities to which transaction applies:
        
 
    (3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
        
 
    (4)   Proposed maximum aggregate value of transaction:
        
 
    (5)   Total fee paid:
        
 

o

 

Fee paid previously with preliminary materials.

o

 

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

 

(1)

 

Amount Previously Paid:
        
 
    (2)   Form, Schedule or Registration Statement No.:
        
 
    (3)   Filing Party:
        
 
    (4)   Date Filed:
        
 

 

 

 

 

Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

NUTRACEUTICAL INTERNATIONAL CORPORATION

** IMPORTANT NOTICE **

Regarding the Availability of Proxy Material

        You are receiving this communication because you hold shares in the above company, and the material you should review before you cast your vote is now available.

        This communication presents only an overview of the more complete proxy material that is available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy material before voting.

Nutraceutical International Corporation

1400 Kearns Boulevard, 2nd Floor
Park City, Utah 84060

Stockholder Meeting to be held on January 29, 2009

Proxy Material Available

    Notice & Proxy Statement

    Annual Report

PROXY MATERIAL—VIEW OR RECEIVE

You can choose to view the material Online or receive a paper or e-mail copy. There is NO charge for requesting a copy. Requests, instructions and other inquiries will NOT be forwarded to your investment advisor.

To facilitate timely delivery, please make the request as instructed below on or before January 19, 2009.

HOW TO VIEW MATERIAL VIA THE INTERNET

Have the 12 Digit Control Number(s) available and visit: www.proxyvote.com

HOW TO REQUEST A COPY OF MATERIAL

1)  BY INTERNET   - www.proxyvote.com
2)  BY TELEPHONE   - 1-800-579-1639
3)  BY E-MAIL*   - sendmaterial@proxyvote.com

*If requesting material by e-mail, please send a blank e-mail with the 12 Digit Control Number (located on the following page) in the subject line.

See the Reverse Side for Meeting Information and Instructions on How to Vote


Meeting Information

 
   
   
Meeting Type:   Annual Meeting    
Meeting Date:   January 29, 2009    
Meeting Time:   9:00 A.M, MST    
For holders as of:   December 12, 2008    

Meeting Location:
Business Depot in Ogden
530 West 2nd Street
Building 2A
Ogden, Utah 84404

How To Vote

 
   
[Person Graphic]   Vote In Person

Should you choose to vote these shares in person at the meeting you must request a "legal proxy". To request a legal proxy please follow the instructions at www.proxyvote.com or request a paper copy of the material. Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting material for any special requirements for meeting attendance.
   
 

[Computer Graphic]

 

Vote By Internet

To vote now by Internet, go to WWW.PROXYVOTE.COM.

 

 

Please refer to the proposals and follow the instructions.

Voting items

The Board of Directors recommends that you vote "For" the following.

1.
Election of Directors

      Nominees:

        01
        Michael D. Burke Class II

        02
        James D. Stice Class II

The Board of Directors recommends you vote FOR the following proposal(s).

2.
To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the fiscal year ending September 30, 2009.


-----END PRIVACY-ENHANCED MESSAGE-----